These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32521458)

  • 41. Research Progress in the Modification of Quercetin Leading to Anticancer Agents.
    Massi A; Bortolini O; Ragno D; Bernardi T; Sacchetti G; Tacchini M; De Risi C
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28758919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular Disease: A Target for the Pharmacological Effects of Quercetin.
    Gormaz JG; Quintremil S; Rodrigo R
    Curr Top Med Chem; 2015; 15(17):1735-42. PubMed ID: 25915608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disposition of the flavonoid quercetin in rats after single intravenous and oral doses.
    Khaled KA; El-Sayed YM; Al-Hadiya BM
    Drug Dev Ind Pharm; 2003 Apr; 29(4):397-403. PubMed ID: 12737533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intracellular ROS protection efficiency and free radical-scavenging activity of quercetin and quercetin-encapsulated liposomes.
    Rezaei-Sadabady R; Eidi A; Zarghami N; Barzegar A
    Artif Cells Nanomed Biotechnol; 2016; 44(1):128-34. PubMed ID: 24959911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of nanosuspension formulation for oral delivery of quercetin.
    Sun M; Gao Y; Pei Y; Guo C; Li H; Cao F; Yu A; Zhai G
    J Biomed Nanotechnol; 2010 Aug; 6(4):325-32. PubMed ID: 21323105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanotechnological Innovations Enhancing the Topical Therapeutic Efficacy of Quercetin: A Succinct Review.
    Nasr M; Al-Karaki R
    Curr Drug Deliv; 2020; 17(4):270-278. PubMed ID: 32183669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug design strategies that aim to improve the low solubility and poor bioavailability conundrum in quercetin derivatives.
    Alizadeh SR; Savadkouhi N; Ebrahimzadeh MA
    Expert Opin Drug Discov; 2023; 18(10):1117-1132. PubMed ID: 37515777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
    Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
    Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and bioavailability of the flavonol quercetin in humans.
    Graefe EU; Derendorf H; Veit M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):219-33. PubMed ID: 10363620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lecithin-Stabilized Polymeric Micelles (L
    Chang CE; Hsieh CM; Huang SC; Su CY; Sheu MT; Ho HO
    Sci Rep; 2018 Dec; 8(1):17640. PubMed ID: 30518853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioavailability of the flavonol quercetin in neonatal calves after oral administration of quercetin aglycone or rutin.
    Maciej J; Schäff CT; Kanitz E; Tuchscherer A; Bruckmaier RM; Wolffram S; Hammon HM
    J Dairy Sci; 2015 Jun; 98(6):3906-17. PubMed ID: 25795488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microporous Frameworks as Promising Platforms for Antibacterial Strategies Against Oral Diseases.
    Wan Y; Xu W; Ren X; Wang Y; Dong B; Wang L
    Front Bioeng Biotechnol; 2020; 8():628. PubMed ID: 32596233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
    Choi JS; Piao YJ; Kang KW
    Arch Pharm Res; 2011 Apr; 34(4):607-13. PubMed ID: 21544726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quercetin-containing self-assemble proliposome preparation and evaluation.
    Ren J; Fang Z; Jiang L; Du Q
    J Liposome Res; 2017 Dec; 27(4):335-342. PubMed ID: 27667265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioavailability and metabolism of the flavonol quercetin in the pig.
    Ader P; Wessmann A; Wolffram S
    Free Radic Biol Med; 2000 Apr; 28(7):1056-67. PubMed ID: 10832067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of pH-Responsive Fucoidan/Chitosan Nanoparticles to Improve Oral Quercetin Delivery.
    Barbosa AI; Costa Lima SA; Reis S
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30669398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study.
    Chen LC; Chen YC; Su CY; Hong CS; Ho HO; Sheu MT
    Int J Nanomedicine; 2016; 11():1557-66. PubMed ID: 27143878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incorporation of quercetin in respirable lipid microparticles: effect on stability and cellular uptake on A549 pulmonary alveolar epithelial cells.
    Scalia S; Trotta V; Traini D; Young PM; Sticozzi C; Cervellati F; Valacchi G
    Colloids Surf B Biointerfaces; 2013 Dec; 112():322-9. PubMed ID: 24012702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-encapsulation of biodegradable nanoparticles with silicon quantum dots and quercetin for monitored delivery.
    Wang Q; Bao Y; Ahire J; Chao Y
    Adv Healthc Mater; 2013 Mar; 2(3):459-66. PubMed ID: 23184534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges.
    Lockhart JN; Stevens DM; Beezer DB; Kravitz A; Harth E
    J Control Release; 2015 Dec; 220(Pt B):751-7. PubMed ID: 26344396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.